Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer | 3 | |||||
| A multi-center open-label parallel group randomized controlled trial to compare iGlarLixi versus premixed insulin in patients with type 2 diabetes who have failed to achieve glycemic control with basal insulin and oral antidiabetic agents | ||||||
| REFINE: Regorafenib observational study in hepatocellular carcinoma | 4 | |||||
| Use of high dose of Colistin in Multidrug Resistant Gram Negative infections. Randomized Controlled clinical Trial | King Saud Medical City | Completed | Colistin | 4 | KSMC-12-13 | King Saud Medical City |
| "easypod connect: A regional, Multicentre, Observational study to evaluate Adherenceand Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment" | Merck Serono | Rejected | - | 4 | 200104-534 | King Khalid University Hospital (Riyadh) |
| "AN OBSERVATIONAL, NON-INTERVENTIONAL,MULTI-CENTER, MULTI-NATIONAL STUDY OFPATIENTS WITH ATYPICAL HEMOLYTIC-UREMICSYNDROME(AHUS REGISTRY)" | Alexion | Rejected | - | 4 | M11-001 | N/A |
| A Phase IV Double-Blind Placebo-Controlled Randomized Clinical Trial Assessing the Effect of 2 month consumption of Vetal Laban Including Lactobacillus acidophilus NCFM on Functional Gastrointestinal Symptoms Among Subjects Fulfilling Rome III Criteria for A Phase IV, Randomized, double-blind, placebo-controlled study with parallel groups Irritable Bowel Syndrome | Almarai | Rejected | Vetal Laban containing Lactobacillus acidophilus NCFM at 1.6 x 109 CFU per container | 4 | IBS - 0920 | King Fahad Medical City (Riyadh) |
| "An Open-label, Multicentre, Randomised, 2-arm Study to Investigate the Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose Versus Oral Iron for the Treatment of Iron Deficiency Anaemia in Pregnant Women" | Vifor Pharma | Terminated | Ferrous Sulphate + Ferinject | 3 | FER-ASAP-2009-01 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| The Effectiveness of Convalescent Plasma for the Treatment of Severe COVID-19 Cases in Intensive Care Unit | King Faisal Specialist Hospital and Research Centre | Ongoing | Convalescent Plasma | 3 | IRB 2020-19-V2 | King Faisal Specialist Hospital and Research Center (Jeddah) |
| An Open Label, Phase IV, Multi-Centric, Prospective, Single Arm Study to Assess the Safety and Efficacy of Dexaflox Eye Drops Containing Ofloxacin (3 mg) and dexamethasone (1 mg) in Subjects with Bacterial Conjunctivitis | Jamjoom Pharmaceuticals | Completed | Dexaflox | 4 | DEXA001 | King Khalid University Hospital (Riyadh) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.